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ABSTRACT 
 
Stenotrophomonas maltophilia is an important opportunistic nosocomial pathogen that 
shows intrinsic resistance to many antibiotics. This often limits treatment options and can 
cause lengthy hospital stays. Combination treatments are often used to combat resistance and 
using natural compounds such as polyphenols could give increased treatment options and 
even the reuse of antibiotics to which high levels of resistance have been observed. A 
checkerboard assay was used to determine if any synergy exists between ampicillin and the 
polyphenol theaflavin against 9 clinical isolates and one control isolate (NCTC 13014) of S. 
maltophilia. It was discovered that significant synergy (P  0.05) does exist between 
theaflavin and ampicillin, reducing the mean MIC of ampicillin from 12.5-22.9 µg/mL, in 
liquid culture, to 3.125-6.25 µg/mL. The FIC index was calculated to be 0.22-0.35 confirming 
synergy. From these results, significant potential for medical applications can be seen and 
further investigation is recommended. 
 
Keywords: antibacterial, theaflavin, polyphenol, synergy, checkerboard, Stenotrophomonas 
maltophilia 
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INTRODUCTION 
 
Throughout the world, pathogens are increasingly exhibiting resistance to clinically 
available antibiotics (Karchmer, 2004). Bacterial resistance to antibiotics has been described 
as a natural phenomenon resulting from selective pressure due to continued exposure to their 
presence (Guillemot, 1999). There are five major mechanisms that underlie bacterial 
resistance: target site modification, enzyme-catalyzed inactivation, metabolic by-pass, efflux 
or prevention of antibiotic entry into cells (Alanis, 2005). All groups of antibiotics have 
associated resistance and in some cases manufacturers have been forced to modify their 
structures in an attempt to reverse this. Despite modifications, resistance to the modified drugs 
can rapidly arise. 
Stenotrophomonas maltophilia is an opportunistic pathogen, which can readily 
colonise epithelial cells in the human respiratory tract often leading to pneumonia in immune-
compromised patients, individuals with cystic fibrosis and those on respirators (Alonso and 
Martinez, 1997; Looney, et al., 2009). This bacterium possesses intrinsic resistance to 
important clinical antibiotics (San Gabriel et al., 2004) and combination therapy can be 
required to treat infections.  
The use of antibiotic formulations containing two or more active agents has its basis in 
successful therapy and is particularly valuable in preventing future emergence of antibiotic 
resistance. However, this would not be the case for resistance genes acquired by bacteria, 
through horizontal gene transfer. Beyond the traditional antibiotic cocktails it is likely that 
there are many antibacterial mixtures yet to be identified. Combining clinical antibiotics with 
non-traditional antibacterial agents could provide treatments that are more effective than using 
the antibiotic alone (Cushine and Lamb, 2011). 
Natural compounds such as the polyphenols found in tea may provide promising 
additions to the armoury of conventional drugs, in order to meet the urgent requirement for 
new antimicrobial therapies to help combat the resistance problem.  For example, the 
polyphenol theaflavin, found in black tea has been shown to possess antimicrobial activity 
against bacteria including Bacillus cereus and Shigella spp. (Vijaya et al., 1995; Friedman et 
al., 2006). Both Acinetobacter baumannii and S. maltophilia have been shown to be 
susceptible to the green tea polyphenol epigallocatechin gallate (Osterburg et al., 2009; 
Gordon and Wareham, 2010).  
The possible synergies between tea-derived compounds and other antibiotics have 
important implications and potential applications. Investigations into the synergies of 
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flavanols with other compounds such as ascorbic acid (Hatano et al., 2008) and polyphenols 
(Betts et al., 2011) have proven to be successful by enhancing or prolonging the antibacterial 
action. Previously the green tea polyphenol epicatechin gallate was shown to reverse the 
resistance of Methicillin-resistant Staphylococcus aureus (MRSA) to oxacillin (Anderson et 
al., 2005). Also, epigallocatechin gallate (EGCG) showed synergy with the macrolide 
antibiotic clarithromycin (Yanagawa et al., 2003). Flavanoids, including epicatechin from 
tea, reduced the minimum inhibitory concentrations (MICs) of isoniazid in Mycobacterium 
smegmatis (Lechner et al., 2008). Some conflicting research suggests that a gallate group 
must be present for any synergy to be shown (Stapleton et al., 2004). 
Very little research has been published to provide evidence of synergy between 
theaflavin and antibiotics. Previous research (Neyestani et al., 2007) has shown that black tea 
extracts cause synergistic and antagonistic effects when applied with various antibiotics 
against Streptococcus pyogenes. However, this research used a crude black tea mixture and 
did not identify the specific compounds responsible for the observed effects. Previous 
research (Tiwari et al., 2005) has also found synergy between black tea extracts and 
antibiotics such as chloramphenicol and gentamicin against various pathogens including 
Shigella dysenteriae and Salmonella enterica serovar Typhimurium. This work also suggested 
that the synergy results from the exploitation of dual binding sites on the surface of the 
bacteria. Although like previous research (Neyestani et al., 2007) mixed tea extracts were 
used and the active chemical components were not purified. The rationale of using 
polyphenols with antibiotics is the possibility of effectively reusing antibiotics such as Beta-
lactams, in the treatment of bacterial infections, where resistance has previously shown them 
to be ineffective.  
The objective of the preliminary research described in this paper was to assess whether 
any synergistic effects exist between ampicillin with theaflavin against clinical isolates of 
Stenotrophomonas maltophilia.  
 
MATERIAL AND METHODS 
 
Clinical and control isolates 
 
Nine strains of S. maltophilia were isolated over three months from sputum samples of 
respiratory patients at the Hull Royal Infirmary, UK. All isolates were cultured on blood and 
MacConkey agar (Oxoid, Basingstoke, UK) and identified using Gram staining, BSAC 
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(British Society for Antimicrobial Chemotherapy)  antibiotic susceptibility testing (Andrews, 
2007) and biochemical profiling with API 20E testing kits (BioMérieux, France). A control 
strain of S. maltophilia (NCTC 13014) was purchased from the Heath Protection Agency 
Cultures Collections, Porton Down, UK. 
 
Culture media, antibiotics and tea polyphenols 
 
Ampicillin (AMP) powder was purchased as ampicillin sodium salt from Sigma-
Aldrich, UK. All media and ampicillin discs were purchased from Oxoid, UK. Ampicillin was 
selected as previous laboratory testing had shown that 25 g discs containing ampicillin 
produced no zones of inhibition against S. maltophilia (Betts et al., 2012) and therefore 
resistance was concluded. All media and materials were autoclaved before their use. 
Theaflavin (TF) with purity  95 was donated by Unilever, Shanghai, China. 
 
Ampicillin susceptibility testing 
 
All isolates were inoculated onto IsoSensitest agar (Oxoid, UK) using the method 
standardised by Moodsdeen, Williams and Secker (1988). Ten IsoSensitest agar plates       
(6 mm in depth) were poured and inoculated with the control strain and each of the 9 clinical 
isolates. Discs were added containing ampicillin (25 g). All isolates were incubated at 30C 
for 20 h, in accordance with the BSAC methods (BSAC, 2012) of susceptibility testing for S. 
Maltophilia (Andrews, 2007). At the end of the incubation period, for each test disc the 
diameter of the disc plus zone of inhibition was measured (mm) and recorded. Each 
experimental plate was replicated six times to check for consistency.  
 
Checkerboard assay 
 
Stock solutions of theaflavin and ampicillin were initially made up in 0.5 mL of 100% DMSO 
based on the method by Gordon and Wareham (2010), for ease of solubility. Stock solutions 
were then diluted into 19.5 mL of ISO-sensitive broth leaving DMSO concentrations of 2.5%. 
To a standard 96-well round-bottomed microtitre plate, 50 µL of the theaflavin and ampicillin 
solutions were pipetted into each well, so that each row and column contained a fixed amount 
of one antimicrobial agent and increasing concentrations of the other. This gave final well 
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concentrations of 3.125-800 µg/mL of theaflavin and 3.25-100 µg/mL of ampicillin (Figure 
1).  To inoculate each well with S. maltophilia, a 100 L volume of a 0.5 MacFarland 
suspension of was pipetted (Andrews, 2001). This procedure was replicated for each isolate 
tested. All microtitre plates were incubated at 30C for 24 h. Control wells were also prepared 
using theaflavin in 2.5% DMSO (3.125-800 µg/mL), ampicillin in 2.5% DMSO (3.25-100 
µg/mL) and 2.5% DMSO only. 
 
  
Figure 1 Organisation of the checkerboard assay showing well concentration of theaflavin 
and ampicillin. C1 = Ampicillin alone (no bacterial inoculant), C2 = Ampicillin (in 2.5% 
DMSO) + S. maltophilia, C3 = DMSO only + S. maltophilia, C4 = Theaflavin (in 2.5% 
DMSO) + S. maltophilia and C5 = theaflavin alone (no bacterial inoculant). 
 
At the end of the incubation period, each well was observed for signs of visible 
turbidity. The lowest concentration not showing visible turbidity was taken as the MIC. The 
fractional inhibitory concentrations (FIC) were determined based on the method described by 
Hall, Middleton and Westmacott (1983) whereby the FICa = MIC of compound a + 
compound b/MIC of compound a, the FICb = MIC of compound b + compound a/MIC of 
compound b and the FICs = FICa + FICb. If the FICs index was equal to 0.5 or less, a 
synergistic effect was recorded. A value > 0.5 – 4.0 was taken as an additive effect and a 
value > 4.0 was counted as antagonistic effect between theaflavin and ampicillin. Six-fold 
replication of all checkerboard assays check for consistency and enabling the results to be 
provided as mean values. Significant differences between data sets for each combination of 
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polyphenols were determined using the Wilcoxon Mann–Whitney test, and results showing P 
≤ 0.05 were considered as significant. 
 
RESULTS AND DISCUSSION 
 
Results from the susceptibility testing using 25 µg ampicillin discs, showed that all 
isolates of S. maltophilia presented resistance to ampicillin.  However, from the checkerboard 
assay it was observed that in a liquid culture S. maltophilia isolates were susceptible to 
ampicillin at concentrations of 12.5 µg/mL and above, with mean MICs being 12.5-22.9 
µg/mL depending on the isolate (See table 1).  The MIC of ampicillin was dramatically 
reduced when used in combination with theaflavin. With the mean theaflavin additions of 
6.25-11.46 µg/mL the mean ampicillin MICs against all S. maltophilia were significantly (P < 
0.05) reduced to 3.125-6.25 µg/mL. The FIC indexes of ampicillin and theaflavin 
combinations against each S. maltophilia isolate was calculated to be between 0.22 and 0.35 
confirming that a synergistic, not an additive relationship exists between theaflavin and 
ampicillin. No antimicrobial effects were produced from DMSO alone and no synergy was 
observed between DMSO and ampicillin. 
From the results presented, the differences can be seen between the disc diffusion and 
microtitre assays as methods of showing susceptibility of S. maltophilia to ampicillin. This 
difference confirms previous literature, which mentions the difficulties of accurately 
determining antibiotic susceptibility of S. maltophilia and the unreliability of the disc 
diffusion method (Tatman-Otkun et al., 2005). It has been shown in this study that the 
microtitre assay is more accurate and far more easily standardised, in than it does not rely on 
the slow diffusion of chemical agents into agar, which are highly affected by temperature and 
pH. 
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Table 1 Mean (± standard deviation) minimum inhibitory concentrations (MIC) and the 
fractional inhibitory concentration indexes (FICIs) of ampicillin and theaflavin against 
clinical isolates of S. maltophilia. 
 
Isolate no. 
MIC (µg/mL)  
AMP TF AMP + TF FIC index 
1 12.5 (0) 200 (0) 3.125 (0) + 6.25 (0) 0.28 
2 14.6 (10.4) 200 (0) 3.125 (0) + 6.25 (0) 0.25 
3 12.5 (0) 400 (0) 3.125 (0) + 11.46 (5.2) 0.28 
4 12.5 (0) 200 (0) 3.65 (2.6) + 6.25 (0) 0.32 
5 22.9 (10.4) 400 (0) 6.25 (0) + 11.46 (5.2) 0.30 
6 14.6 (10.4) 200 (0) 4.17 (2.08) + 6.25 (0) 0.32 
7 25 (0) 400 (0) 5.21 (2.1) + 12.5 (0) 0.24 
8 16.6 (8.3) 200 (0) 3.125 (0) + 6.25 (0) 0.22 
9 12.5 (0) 200 (0) 3.65 (2.6) + 11.46 (5.2) 0.35 
Control 12.5 (0) 200 (0) 3.125 (0) + 9.38 (3.13) 0.30 
Amp= ampicillin, TF = theaflavin, Control = Stenotrophomonas maltophilia NCTC 10258. 
 
The results presented confirm previous results regarding the antibacterial activity of 
theaflavin against S. maltophilia (Betts et al., 2012). More importantly, the work 
demonstrates that significant synergy (P ≤ 0.05) exists between theaflavin and ampicillin 
against all isolates of S. maltophilia used in this investigation. The research here refutes the 
findings of other research (Stapleton et al., 2004), which suggest that a gallate group must be 
present for synergy to occur, and instead supports work which indicates that with some 
antibiotics an interaction can exist (Martins et al., 2011).  The mechanism for this is likely to 
involve an interaction with β-lactamase, possibly disabling the enzyme and allowing 
ampicillin to again disrupt peptidoglycan synthesis.  This result supports previous polyphenol 
and antibiotic work (Zhao et al., 2001) where the addition of epigallocatechin gallate (EGCG) 
reversed resistance to penicillin by Staphylococcus aureus. Previous studies have proposed 
that the mechanisms for polyphenol synergy and activity involves modulating the activity of 
intrinsic β-lactamases (Zhao et al., 2002) and also the destabilisation of the bacterial 
cytoplasmic membrane via by production of hydrogen peroxide (Wang, Wang and Xie, 
2010). However, the modes of action require further investigation as other research has 
suggested that the mechanism behind the antibacterial action of polyphenols is the result of 
cell aggregation (Cushnie and Lamb, 2011). This mechanism would lead to decreased cell 
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surface area and result in reduced nutrient uptake and oxygen consumption. As a consequence 
less energy and materials would be available to produce/maintain elements that they rely on 
for their defence against antibiotics, such as β-lactamases and efflux pumps. With these 
resistance mechanisms suppressed, antibiotics such as ampicillin might again become a viable 
option to treat infections caused by multidrug resistant bacteria. 
 
CONCLUSION 
 
In conclusion this is believed to be the first report providing evidence of synergistic 
properties of theaflavin when used in combination with ampicillin against clinical isolates of 
S. maltophilia. These results could lead to further work investigating the use of ampicillin in 
the treatment of S. maltophilia infections, an antibiotic normally not used against the 
bacterium. This work highlights the potential use of natural compounds such as polyphenols 
in a clinical setting to help combat resistance.  The use of conventional antibiotics with 
polyphenols could increase future treatment options and result in the reuse of many antibiotics 
to which high levels of resistance have previously been observed. Further work is 
recommended to investigate the specific mechanisms and underlying interactions between 
theaflavin and β-lactam antibiotics and its wider effectiveness against resistant bacterial 
pathogens.  
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